# Parasite Clearance Time and Time to Recurrent Infection Following Treatment With Artemether/Lumefantrine

> **NCT01998295** · PHASE4 · COMPLETED · sponsor: **Muhimbili University of Health and Allied Sciences** · enrollment: 45 (actual)

## Conditions studied

- Instantaneous Clearance

## Interventions

- **DRUG:** Artemether/lumefantrine

## Key facts

- **NCT ID:** NCT01998295
- **Lead sponsor:** Muhimbili University of Health and Allied Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2012-06
- **Final completion:** 2012-07
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2014-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01998295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01998295, "Parasite Clearance Time and Time to Recurrent Infection Following Treatment With Artemether/Lumefantrine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01998295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*